20 results


Posted on 03.05.2017

Considerations on European transparency rules for the future

Following on the footsteps of our American colleagues, MedTech Europe would like to offer some thoughts on the issue of transparency and disclosure laws and how certain adaptations could help to frame transparency for a new reality. Over the last few years, a number of European countries have passed transparency or disclosure (sometimes also called “Sunshine”) laws […]


Posted on 26.04.2017

A Bridge Towards Convergence Of Ethical Standards In Medtech

The Advamed Latin America Compliance Conference and the upcoming Global MedTech Compliance Conference  Sometimes I feel that compliance is like a jigsaw puzzle where every new piece brings us closer to the complete picture: Codes of Ethics. After being heavily involved in the adoption of the MedTech Europe Code of Business Ethical Practice, during my […]

By Renata De Travieso Legal & Compliance consultant, MedTech Europe


Posted on 26.04.2017

Two Major Privacy Challenges Facing Medtech Companies

I recently sat down with Peter Blenkinsop, a Partner at DrinkerBiddle, an expert on data privacy and one of the panelists at our upcoming GMTCC Conference (Amsterdam, May 3-4), to get his take on the biggest privacy law challenges currently facing Medtech companies. Peter pointed to two trends that are changing the Medtech sector and provided insight on how privacy […]

By Christopher White General Counsel, AdvaMed

GMTCC-banner HR

Posted on 04.04.2017

Building MedTech Compliance for Tomorrow

Each fall the two of us meet to discuss global healthcare legal and compliance developments and to assess implications on the medical technology industry, patient care and innovation. When we first began collaborating the iPhone was just invented (healthcare apps were unimaginable) and, since that time, quite a bit has changed! When we annually meet, […]

By Aline Lautenberg MedTech Europe, General Counsel - Director Legal & Compliance


Posted on 29.03.2017

Looking the Other Way: What About Upstream Corporate Considerations?

As a medtech lawyer, my focus naturally gravitates to assessing “downstream” relationships and risk; that is, analysis of the legal arrangements between manufacturers, distribution agents, and health care providers that together bring medical technologies to the patient’s bedside. These relationships can be complex, as are the legal issues they raise. But ensuring ethical standards in these relationships […]

By Christopher White General Counsel, AdvaMed


Posted on 08.03.2017

Code of Ethical Business Practice: Impressions from interviews with Healthcare Professionals

The MedTech Europe Code of Ethical Business Practice entered into force on the 1st January 2017, with the phase-out of direct sponsorship that needs to be implemented in less than a year from now. The Code has been the topic of many conversations. However, until recently, we did not have the opinion of individual Healthcare […]


Posted on 25.01.2017

Code of Ethical Business Practice: Open letter to the healthcare community

The new MedTech Europe Code of Ethical Business Practice (the “Code”) came in force on the 1st January 2017 and replaces the Eucomed Code of Ethical Business Practices and the EDMA Code of Ethics. The Code allows for an additional year to phase out direct sponsorship by the entire medtech industry but this may be […]


Posted on 24.02.2016

Advancing the standards of ethical business practice worldwide

As a compliance professional, it’s exciting to witness new Codes of Ethics take root worldwide.  Voluntary industry Codes of Ethics serve several important functions.  A credible Code demonstrates industry’s ability to self-regulate, in turn fostering consumer and governmental trust and confidence.  A Code centers stakeholders on the most meaningful business principles that the entire industry […]

By Christopher . L. White, Esq Senior Executive Vice President, General Counsel and Secretary of the Advanced Medical Technology Association (AdvaMed)


Posted on 21.04.2015

Beefing up safeguards against corruption: Where is the medtech industry in 2015?

Eight years ago, I was interviewing executives of a prospective Chinese distributor for my employer, a publicly-traded medical device company based in California. “We understand that it is hard to do business in China without paying kickbacks to physicians and hospital administrators” I observed. “How do you handle this?” Without hesitating, one of the executives […]